BerandaCAMX • STO
add
Camurus AB
Tutup sebelumnya
kr 471,20
Rentang hari
kr 464,40 - kr 476,20
Rentang tahun
kr 455,60 - kr 754,50
Kapitalisasi pasar
28,24Â M SEK
Volume Rata-Rata
175,24Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 464,46Â jt | -16,03% |
Biaya operasional | 315,31Â jt | -12,24% |
Penghasilan bersih | 100,88Â jt | -31,36% |
Margin laba bersih | 21,72 | -18,25% |
Penghasilan per saham | 1,67 | -31,84% |
EBITDA | 119,44Â jt | -27,19% |
Tarif pajak efektif | 20,47% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,73Â M | 30,61% |
Total aset | 4,74Â M | 26,16% |
Total liabilitas | 504,56Â jt | 7,97% |
Total ekuitas | 4,24 M | — |
Saham yang beredar | 59,64 jt | — |
Harga terhadap nilai buku | 6,63 | — |
Tingkat pengembalian aset | 6,02% | — |
Tingkat pengembalian modal | 6,58% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 100,88Â jt | -31,36% |
Kas dari operasi | 255,43Â jt | 147,39% |
Kas dari investasi | -45,79Â jt | -130,25% |
Kas dari pembiayaan | 3,09Â jt | -79,97% |
Perubahan kas bersih | 211,26Â jt | 108,27% |
Arus kas bebas | 104,90Â jt | 273,91% |
Tentang
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Didirikan
1991
Situs
Karyawan
285
